Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial.
Di Santo P, Mathew R, Jung RG, Simard T, Skanes S, Mao B, Ramirez FD, Marbach JA, Abdel-Razek O, Motazedian P, Parlow S, Boczar KE, D'Egidio G, Hawken S, Bernick J, Wells GA, Dick A, So DY, Glover C, Russo JJ, McGuinty C, Hibbert B; CAPITAL DOREMI investigators.
Di Santo P, et al. Among authors: boczar ke.
Crit Care. 2021 Aug 10;25(1):289. doi: 10.1186/s13054-021-03706-2.
Crit Care. 2021.
PMID: 34376218
Free PMC article.
Clinical Trial.